Liquidia to Present at ARVO 2013

Liquidia Technologies, Research Triangle Park, N.C.-based biotechnology company, has announced that it will be presenting two preclinical poster presentations at the Association for Research in Vision and Ophthalmology 2013 annual meeting.

Advertisement

The presentations are titled “Application of PRINT Microparticle and Nanoparticle Technology Toward Preparation of Ophthalmic Suspension Formulations With Improved Tolerability and Efficacy” and “Precisely Engineered Biodegradable Intraocular Implants for the Sustained Release of Dexamethasone.”

More Articles on Ophthalmology:
American Academy of Ophthalmology Grants US Rep. Marsha Blackburn Visionary Award
How Ophthalmologists are Affected by Healthcare Cost Changes: 15 Statistics
Liquidia Technologies to Develop Ophthalmology-Focused Company

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.